Hebei, China

Xiaopeng Liu

This inventor holds 1 USPTO granted patent. Top assignee: Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiaopeng Liu: Innovator in Pharmaceutical Technology

Introduction

Xiaopeng Liu is a notable inventor based in Hebei, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of aldose reductase inhibitors. His work focuses on improving the solubility and stability of medicinal compounds.

Latest Patents

Xiaopeng Liu holds a patent for a "Salt of aldose reductase inhibitor, and preparation method and application thereof." This invention presents a salt of an aldose reductase inhibitor that can be prepared in a crystal form. The salt demonstrates notably improved solubility compared to the original compound, along with lower hygroscopicity, which allows for a more stable existence. This advancement makes it easier to formulate into a medicine than the original compound or other salts.

Career Highlights

Xiaopeng Liu is currently employed at Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. His role in the company has allowed him to focus on innovative solutions in drug development. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in the pharmaceutical industry.

Collaborations

Xiaopeng Liu collaborates with talented individuals such as Zhankun Yang and Hanyu Yang. Their teamwork fosters an environment of innovation and creativity, leading to the development of new pharmaceutical technologies.

Conclusion

Xiaopeng Liu's contributions to the field of pharmaceutical technology highlight his dedication to innovation and improvement in drug formulation. His work on aldose reductase inhibitors showcases the potential for advancements in medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…